Multiple Myeloma 68284528MMY2012 CARTITUDE-10

A Phase 2 Multicohort Trial to Further Characterize the Efficacy and Safety of Ciltacabtagene Autoleucel

Description
The purpose of this study is to evaluate how well (efficacy) cilta-cel works when given with a fludarabine-free lymphodepletion regimen (a process of reducing the number of lymphocytes, a type of white blood cell in the body, typically through chemotherapy), or an alternative administration of cilta-cel infusion following a cyclophosphamide and fludarabine lymphodepletion regimen.

Sponsor: Janssen Research & Development, LLC

Interested in this trial? Email [email protected]

Back To Clinical Trials NCI Database Entry